{
    "id": 268235,
    "user_id": 1699,
    "title": "HIV/AIDS",
    "is_commented": true,
    "is_timed": false,
    "created_at": "2022-07-11T23:10:45.000Z",
    "updated_at": "2022-07-11T23:10:45.000Z",
    "study_plan_id": 199,
    "is_simulated": false,
    "is_completed": false,
    "accurate": null,
    "status": null,
    "questions": [
        {
            "id": 986,
            "institution_id": 4,
            "description": "Assinale a alternativa que apresenta o tipo e subtipo, respectivamente, do v√≠rus HIV mais comum no Brasil:",
            "difficulty": "easy",
            "year": "2020-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T01:59:50.000Z",
            "updated_at": "2020-06-01T01:59:50.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 986
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4045,
                    "question_id": 986,
                    "description": "Tipo I, Subtipo A",
                    "explanation": "O subtipo A n√£o √© o mais comum no Brasil",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-05-31T22:59:50.000Z",
                    "updated_at": "2020-05-31T22:59:50.000Z",
                    "files": []
                },
                {
                    "id": 4046,
                    "question_id": 986,
                    "description": "Tipo I, Subtipo B",
                    "explanation": "Perfeito, esse √© o v√≠rus circulante mais comum no Brasil. No mundo, tamb√©m predomina o tipo I, mas o mais comum √© o subtipo C\nüí°Lembre de****  B de****Brasil",
                    "order": 1,
                    "correct": true,
                    "created_at": "2020-05-31T22:59:50.000Z",
                    "updated_at": "2020-05-31T22:59:50.000Z",
                    "files": []
                },
                {
                    "id": 4047,
                    "question_id": 986,
                    "description": "Tipo I, Subtipo C",
                    "explanation": "Esse √© o tipo e subtipo mais comum no Mundo, mas n√£o no Brasil",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T22:59:50.000Z",
                    "updated_at": "2020-05-31T22:59:50.000Z",
                    "files": []
                },
                {
                    "id": 4048,
                    "question_id": 986,
                    "description": "Tipo II, Subtipo A",
                    "explanation": "N√£o s√£o o tipo nem subtipo mais comuns no Brasil",
                    "order": 3,
                    "correct": false,
                    "created_at": "2020-05-31T22:59:50.000Z",
                    "updated_at": "2020-05-31T22:59:50.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 986,
                "questionary_id": 268235,
                "timer": 81
            }
        },
        {
            "id": 987,
            "institution_id": 4,
            "description": "Assinale a alternativa que corresponde ao tempo de soroconvers√£o do HIV, ou seja, o tempo que demora para os anticorpos serem detect√°veis na corrente sangu√≠nea em testes r√°pidos a partir do momento da infec√ß√£o:",
            "difficulty": "easy",
            "year": "2018-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-05-31T23:02:32.000Z",
            "updated_at": "2022-03-19T20:15:25.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 987
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4049,
                    "question_id": 987,
                    "description": "1 semana",
                    "explanation": "Quest√£o conceitual. Confira o coment√°rio na alternativa correta. ",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-05-31T23:02:32.000Z",
                    "updated_at": "2022-03-19T20:15:25.000Z",
                    "files": []
                },
                {
                    "id": 4050,
                    "question_id": 987,
                    "description": "1 a 2 semanas",
                    "explanation": "Quest√£o conceitual. Confira o coment√°rio na alternativa correta. ",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:02:32.000Z",
                    "updated_at": "2022-03-19T20:15:25.000Z",
                    "files": []
                },
                {
                    "id": 4051,
                    "question_id": 987,
                    "description": "2 a 4 semanas",
                    "explanation": "Quest√£o conceitual. Confira o coment√°rio na alternativa correta.",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T23:02:32.000Z",
                    "updated_at": "2022-03-19T20:15:25.000Z",
                    "files": []
                },
                {
                    "id": 4052,
                    "question_id": 987,
                    "description": "4 a 10 semanas",
                    "explanation": "Perfeito. Quest√£o conceitual fundamental para saber os exames que podemos usar para identificar o HIV na fase aguda.\nO tempo de soroconvers√£o √© de 4-10 semanas, ou seja, pelo menos **28 dias**. Antes disso, a chance de uma sorologia para HIV dar negativa √© quase certa. Doc, a exce√ß√£o aqui √© se for utilizado um ELISA de 4¬™ gera√ß√£o, o que poderia levar a detec√ß√£o de anticorpos nos primeiros 15 dias.",
                    "order": 3,
                    "correct": true,
                    "created_at": "2020-05-31T23:02:32.000Z",
                    "updated_at": "2022-03-19T20:15:25.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 987,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 989,
            "institution_id": 4,
            "description": "Assinale a alternativa que contenha o(s) exame(s) indicado(s) para o diagn√≥stico de infec√ß√£o aguda por HIV:",
            "difficulty": "easy",
            "year": "2020-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:09:50.000Z",
            "updated_at": "2020-06-01T02:09:50.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 989
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4057,
                    "question_id": 989,
                    "description": "Sorologia Anti-HIV",
                    "explanation": "O tempo de soroconvers√£o do HIV √© de pelo menos 28 dias. Logo, a chance de uma sorologia vir negativa antes de 28 dias ap√≥s a infec√ß√£o √© muito grande",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-05-31T23:09:50.000Z",
                    "updated_at": "2020-05-31T23:09:50.000Z",
                    "files": []
                },
                {
                    "id": 4058,
                    "question_id": 989,
                    "description": "Sorologia anti-HIV, ant√≠geno p24 ou carga viral",
                    "explanation": "O tempo de soroconvers√£o do HIV √© de pelo menos 28 dias. Logo, a chance de uma sorologia vir negativa antes de 28 dias ap√≥s a infec√ß√£o √© muito grande ",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:09:50.000Z",
                    "updated_at": "2020-05-31T23:09:50.000Z",
                    "files": []
                },
                {
                    "id": 4059,
                    "question_id": 989,
                    "description": "Apenas a carga viral",
                    "explanation": "O ant√≠geno p24 aparece precocemente na infec√ß√£o pelo HIV, sendo √∫til no diagn√≥stico da fase aguda",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T23:09:50.000Z",
                    "updated_at": "2020-05-31T23:09:50.000Z",
                    "files": []
                },
                {
                    "id": 4060,
                    "question_id": 989,
                    "description": "Carga viral ou ant√≠geno p24",
                    "explanation": "Perfeito. A carga viral pode ser positiva j√° em 6 dias ap√≥s o cont√°gio e o ant√≠geno p24 pode ser encontrado a partir de 10 dias do cont√°gio",
                    "order": 3,
                    "correct": true,
                    "created_at": "2020-05-31T23:09:50.000Z",
                    "updated_at": "2020-05-31T23:09:50.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 989,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 990,
            "institution_id": 4,
            "description": "Sobre os perfis de progress√£o de infec√ß√£o por HIV para AIDS nos pacientes infectados, julgue as afirmativas:\n- I.Controladores de elite conseguem manter uma carga viral <50 c√≥pias\n- II.N√£o progressores n√£o evoluem para a doen√ßa AIDS, apesar de ter carga viral detect√°vel\n- III.N√£o progressores de longo tempo: demoram mais de 10 anos para progredir para AIDS\n- IV: Progressores r√°pidos demoram, em m√©dia, 6 meses para progredir para AIDS",
            "difficulty": "easy",
            "year": "2016-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:14:43.000Z",
            "updated_at": "2022-03-19T20:40:01.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 990
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4061,
                    "question_id": 990,
                    "description": "Apenas o conceito de I est√° correto",
                    "explanation": "Confira o coment√°rio completo na alternativa correta ",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-05-31T23:14:43.000Z",
                    "updated_at": "2022-03-19T20:40:01.000Z",
                    "files": []
                },
                {
                    "id": 4062,
                    "question_id": 990,
                    "description": "Apenas I e II apresentam conceitos corretos",
                    "explanation": "Confira o coment√°rio completo na alternativa correta ",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:14:43.000Z",
                    "updated_at": "2022-03-19T20:40:01.000Z",
                    "files": []
                },
                {
                    "id": 4063,
                    "question_id": 990,
                    "description": "Apenas I, II e III apresentam conceitos corretos",
                    "explanation": "Confira o coment√°rio completo na alternativa correta",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T23:14:43.000Z",
                    "updated_at": "2022-03-19T20:40:01.000Z",
                    "files": []
                },
                {
                    "id": 4064,
                    "question_id": 990,
                    "description": "Todos os conceitos, de I a IV, est√£o corretos",
                    "explanation": "Cada paciente responde com seu sistema imunol√≥gica de forma diferente ao v√≠rus HIV. De acordo com velocidade de progress√£o para AIDS, podemos classificar os pacientes em:\n\n- I.Controladores de elite ‚û° conseguem manter uma carga viral <50 c√≥pias\n- II.N√£o progressores ‚û° n√£o evoluem para a doen√ßa AIDS, apesar de ter carga viral detect√°vel\n- **III.N√£o progressores de longo tempo:** demoram mais de 10 anos para progredir para AIDS => A maioria dos pacientes se encontra nesse perfil\n- IV: Progressores r√°pidos ‚û° demoram, em m√©dia, 6 meses para progredir para AIDS ",
                    "order": 3,
                    "correct": true,
                    "created_at": "2020-05-31T23:14:43.000Z",
                    "updated_at": "2022-03-19T20:40:01.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 990,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 992,
            "institution_id": 4,
            "description": "Em pacientes com infec√ß√£o pelo HIV com quadro neurol√≥gico subagudo de encefalopatia, a principal hip√≥tese diagn√≥stica deve ser:",
            "difficulty": "easy",
            "year": "2020-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:23:25.000Z",
            "updated_at": "2020-06-01T02:23:25.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 992
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4069,
                    "question_id": 992,
                    "description": "Linfoma 1¬∫ do Sistema Nervoso Central",
                    "explanation": "√â uma das principais causas de encefalopatia no paciente HIV, mas n√£o √© a principal",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-05-31T23:23:25.000Z",
                    "updated_at": "2020-05-31T23:23:25.000Z",
                    "files": []
                },
                {
                    "id": 4070,
                    "question_id": 992,
                    "description": "Neurotuberculose",
                    "explanation": "Pacientes HIV s√£o mais propensos a ter infec√ß√£o grave por TB, mas n√£o √© a principal hip√≥tese. Al√©m de neuroTB ter um quadro mais arrastado e longo de altera√ß√£o gradual do comportamento",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:23:25.000Z",
                    "updated_at": "2020-05-31T23:23:25.000Z",
                    "files": []
                },
                {
                    "id": 4071,
                    "question_id": 992,
                    "description": "Neurotoxoplasmose",
                    "explanation": "Perfeito. A principal hip√≥tese diagn√≥stica a ser pensada em paciente HIV com encefalopatia √© a neurotoxoplasmose. Na TC, observamos imagem com realce anelar, caracter√≠stico da doen√ßa. \nO tratamento √© feito com Sulfadiazina + Pirimetamina + √Åcido Fol√≠nico por 6 semanas",
                    "order": 2,
                    "correct": true,
                    "created_at": "2020-05-31T23:23:25.000Z",
                    "updated_at": "2020-05-31T23:23:25.000Z",
                    "files": []
                },
                {
                    "id": 4072,
                    "question_id": 992,
                    "description": "LEMP",
                    "explanation": "A Lucoencefalopatia Multifocal Progressiva est√° entre as principais causas de encefalopatia em paciente HIV, mas n√£o √© a principal",
                    "order": 3,
                    "correct": false,
                    "created_at": "2020-05-31T23:23:25.000Z",
                    "updated_at": "2020-05-31T23:23:25.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 992,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 993,
            "institution_id": 4,
            "description": "Sobre a pneumocistose em paciente com HIV, assinale o que for incorreto:",
            "difficulty": "easy",
            "year": "2020-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:27:50.000Z",
            "updated_at": "2020-06-01T02:27:50.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 993
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4073,
                    "question_id": 993,
                    "description": "Os n√≠veis de LDH sangu√≠neo costumam estar normais ou baixos",
                    "explanation": "Falso. Uma caracter√≠stica da infec√ß√£o por pneumocistose em indiv√≠duos com HIV s√£o os n√≠veis elevados de LDH, acima de 220.",
                    "order": 0,
                    "correct": true,
                    "created_at": "2020-05-31T23:27:50.000Z",
                    "updated_at": "2020-05-31T23:27:50.000Z",
                    "files": []
                },
                {
                    "id": 4074,
                    "question_id": 993,
                    "description": "O indiv√≠duo apresenta dispneia, aumento da frequ√™ncia respirat√≥ria e dessatura√ß√£o",
                    "explanation": "Perfeito, s√£o caracter√≠sticas cl√°ssicas da apresenta√ß√£o por pneumocistose",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:27:50.000Z",
                    "updated_at": "2020-05-31T23:27:50.000Z",
                    "files": []
                },
                {
                    "id": 4075,
                    "question_id": 993,
                    "description": "O raio X de t√≥rax pode mostrar um infiltrado difuso, mais acentuado na regi√£o peri-hilar",
                    "explanation": "Perfeito, o padr√£o mais caracter√≠stico no Raio X √© um infiltrado difuso, mais concentrado na regi√£o peri-hilar\n\n",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T23:27:50.000Z",
                    "updated_at": "2021-03-11T01:58:18.000Z",
                    "files": [
                        {
                            "id": 249,
                            "file": "1590967628788.jpeg",
                            "name": "download.jpg",
                            "path": "uploads",
                            "type": "image",
                            "subtype": "jpeg",
                            "created_at": "2020-06-01T02:27:09.000Z",
                            "updated_at": "2020-06-01T02:27:09.000Z",
                            "url": "https://qbank.s3.sa-east-1.amazonaws.com/uploads/1590967628788.jpeg",
                            "description": null,
                            "source": null,
                            "overlay_id": null,
                            "user_id": null,
                            "pivot": {
                                "file_id": 249,
                                "alternative_id": 4075
                            }
                        }
                    ]
                },
                {
                    "id": 4076,
                    "question_id": 993,
                    "description": "O tratamento √© feito com Sulfametoxazol + Trimetroprim",
                    "explanation": "Perfeito. Al√©m dessas medica√ß√µes, em caso de satura√ß√£o de O2 diminu√≠da administramos tamb√©m corticoide",
                    "order": 3,
                    "correct": false,
                    "created_at": "2020-05-31T23:27:50.000Z",
                    "updated_at": "2020-05-31T23:27:50.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 993,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 995,
            "institution_id": 4,
            "description": "Mesmo na aus√™ncia de sintomas, a terapia antirretroviral est√° indicada para todos indiv√≠duos comprovadamente infectados pelo v√≠rus do HIV. Sabendo disso, qual √© a terapia inicial de escolha segundo o Minist√©rio da Sa√∫de?",
            "difficulty": "easy",
            "year": "2020-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:34:03.000Z",
            "updated_at": "2020-06-01T02:34:03.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 995
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4082,
                    "question_id": 995,
                    "description": "Tenofovir (TDF) + Lamivudina(3TC) + Dolutegravir",
                    "explanation": "Perfeito. Essa √© a associa√ß√£o de primeira escolha. Em caso de efeitos colaterais ou contra-indica√ß√µes esse esquema pode ser adaptado.\nO motivo principal para o in√≠cio da terapia em indiv√≠duos que ainda n√£o apresentam sintomas √© a diminui√ß√£o da chance de transmiss√£o, pois com a terapia h√° maior chance de tornar a carga viral indetect√°vel",
                    "order": 0,
                    "correct": true,
                    "created_at": "2020-05-31T23:34:03.000Z",
                    "updated_at": "2020-05-31T23:34:03.000Z",
                    "files": []
                },
                {
                    "id": 4083,
                    "question_id": 995,
                    "description": "Tenofovir (TDF) + Lamivudina(3TC) + Efavirenz",
                    "explanation": "O efavirenz n√£o faz parte das medica√ßoes de primeira escolha",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:34:03.000Z",
                    "updated_at": "2020-05-31T23:34:03.000Z",
                    "files": []
                },
                {
                    "id": 4084,
                    "question_id": 995,
                    "description": "Tenofovir (TDF) + Lamivudina(3TC) + Ritonavir",
                    "explanation": "O Ritonavir n√£o faz parte das medica√ß√µes de primeira escolha",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T23:34:03.000Z",
                    "updated_at": "2020-05-31T23:34:03.000Z",
                    "files": []
                },
                {
                    "id": 4085,
                    "question_id": 995,
                    "description": "Entecavir + Lamivudina(3TC) + Dolutegravir",
                    "explanation": "O Entecavir n√£o faz parte das medica√ß√µes de primeira escolha para HIV",
                    "order": 3,
                    "correct": false,
                    "created_at": "2020-05-31T23:34:03.000Z",
                    "updated_at": "2020-05-31T23:34:03.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 995,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 1000,
            "institution_id": 54,
            "description": "√â correto afirmar, sobre a infec√ß√£o aguda por HIV (v√≠rus da imunodefici√™ncia humana), que:",
            "difficulty": "easy",
            "year": "2018-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:59:48.000Z",
            "updated_at": "2020-06-01T02:59:48.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 54,
                "title": "IOG",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-21T22:21:47.000Z",
                "updated_at": "2020-05-21T22:21:47.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 1000
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4104,
                    "question_id": 1000,
                    "description": "cerca de 70% dos pacientes s√£o assintom√°ticos",
                    "explanation": "Cerca de 50% s√£o assintom√°ticos",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-05-31T23:59:48.000Z",
                    "updated_at": "2020-05-31T23:59:48.000Z",
                    "files": []
                },
                {
                    "id": 4105,
                    "question_id": 1000,
                    "description": "o diagn√≥stico cl√≠nico √© obtido em cerca de 80% dos pacientes que apresentam sintomas",
                    "explanation": "O diagn√≥stico cl√≠nico √© muito dif√≠cil, pois os sintomas parecem as doen√ßas mono-like",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:59:48.000Z",
                    "updated_at": "2020-05-31T23:59:48.000Z",
                    "files": []
                },
                {
                    "id": 4106,
                    "question_id": 1000,
                    "description": "meningite com predom√≠nio linfomonocit√°rio e cultura negativa pode ser atribu√≠da a infec√ß√£o aguda pelo HIV",
                    "explanation": "Perfeito. Esse tipo de achado √© dito \"meningite ass√©ptica\" e √© frequente. Ocorre aumento de celularidade com predom√≠nio linfomonocit√°rio, mas a cultura √© negativa",
                    "order": 2,
                    "correct": true,
                    "created_at": "2020-05-31T23:59:48.000Z",
                    "updated_at": "2020-05-31T23:59:48.000Z",
                    "files": []
                },
                {
                    "id": 4107,
                    "question_id": 1000,
                    "description": "a sorologia para HIV (ELISA no soro ou teste r√°pido) torna-se positiva em m√©dia 90 dias ap√≥s a infec√ß√£o, pois detecta anticorpos da classe IgG, os quais aparecem tardiamente",
                    "explanation": "A m√©dia varia entre 21 e 28 dias para positivar nos exames ELISA dispon√≠veis hoje. 90 dias √© muito tempo",
                    "order": 3,
                    "correct": false,
                    "created_at": "2020-05-31T23:59:48.000Z",
                    "updated_at": "2020-05-31T23:59:48.000Z",
                    "files": []
                },
                {
                    "id": 4108,
                    "question_id": 1000,
                    "description": "nenhuma das anteriores",
                    "explanation": "Confira o coment√°rio na alternativa correta",
                    "order": 4,
                    "correct": false,
                    "created_at": "2020-05-31T23:59:48.000Z",
                    "updated_at": "2020-05-31T23:59:48.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 1000,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 12611,
            "institution_id": 608,
            "description": "Com rela√ß√£o a profilaxia da pneumocistose em paciente HIV positivo, marque a alternativa INCORRETA:  ",
            "difficulty": "easy",
            "year": "2011-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2022-02-07T01:52:36.000Z",
            "updated_at": "2022-06-01T20:25:43.000Z",
            "user_id": 2296,
            "is_residency": false,
            "institution": {
                "id": 608,
                "title": "HOSPITAL DA POL√çCIA MILITAR DE MINAS GERAIS,",
                "state": null,
                "is_enabled": true,
                "created_at": "2022-02-07T01:52:36.000Z",
                "updated_at": "2022-02-07T01:52:36.000Z"
            },
            "disciplines": [
                {
                    "id": 1067,
                    "title": "Sulfonamidas",
                    "description": null,
                    "parent_id": 483,
                    "is_enabled": true,
                    "created_at": "2022-01-04T04:32:54.000Z",
                    "updated_at": "2022-01-04T04:32:54.000Z",
                    "pivot": {
                        "discipline_id": 1067,
                        "question_id": 12611
                    }
                },
                {
                    "id": 483,
                    "title": "Antibioticoterapia",
                    "description": null,
                    "parent_id": 172,
                    "is_enabled": true,
                    "created_at": "2020-09-25T16:19:38.000Z",
                    "updated_at": "2021-12-21T04:46:04.000Z",
                    "pivot": {
                        "discipline_id": 483,
                        "question_id": 12611
                    }
                },
                {
                    "id": 175,
                    "title": "Antibi√≥ticos",
                    "description": null,
                    "parent_id": 172,
                    "is_enabled": true,
                    "created_at": "2020-06-09T16:55:00.000Z",
                    "updated_at": "2020-06-09T16:55:00.000Z",
                    "pivot": {
                        "discipline_id": 175,
                        "question_id": 12611
                    }
                },
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 12611
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 51719,
                    "question_id": 12611,
                    "description": "Deve ser mantida por pelo menos 3 meses. ",
                    "explanation": "Essa afirmativa √© verdadeira Doc üòÄ. Para suspendermos o ATB profil√°tico, o paciente deve sustentar uma contagem de linf√≥citos TCD4 >200 por pelo menos 3 meses.",
                    "order": 0,
                    "correct": false,
                    "created_at": "2022-02-07T01:52:36.000Z",
                    "updated_at": "2022-06-01T20:25:43.000Z",
                    "files": []
                },
                {
                    "id": 51720,
                    "question_id": 12611,
                    "description": " Droga de escolha √© sulfametoxazol + trimetoprima.",
                    "explanation": "Outra afirmativa cert√≠ssima Doc üòé a SMX-TMP (800/160mg)  √© o antibi√≥tico de escolha e √© recomendada na dose de 3x na semana. Pode ser substitu√≠da por Dapsona ou Pentamidina, em caso de alergia.",
                    "order": 1,
                    "correct": false,
                    "created_at": "2022-02-07T01:52:36.000Z",
                    "updated_at": "2022-06-01T20:25:43.000Z",
                    "files": []
                },
                {
                    "id": 51721,
                    "question_id": 12611,
                    "description": "Deve-se descontinuar profilaxia uma vez que a contagem de linf√≥cito CD4 T >200 ¬µ.",
                    "explanation": "Exato Doc! üòÅ Assim que os CD4 permanecerem acima de 200, de maneira sustentada, podemos suspender a profilaxia.",
                    "order": 2,
                    "correct": false,
                    "created_at": "2022-02-07T01:52:36.000Z",
                    "updated_at": "2022-06-01T20:25:43.000Z",
                    "files": []
                },
                {
                    "id": 51722,
                    "question_id": 12611,
                    "description": "Contagem de linf√≥cito CD4 T< 300 ¬µ √© indica√ß√£o de profilaxia. ",
                    "explanation": "Afirmativa incorreta Doc ü§ì. A indica√ß√£o √© para contagens abaixo de 200 ¬µ! ",
                    "order": 3,
                    "correct": true,
                    "created_at": "2022-02-07T01:52:36.000Z",
                    "updated_at": "2022-06-01T20:25:43.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 12611,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 13650,
            "institution_id": 4,
            "description": "Pessoas HIV+, em sua grande maioria, devem fazer o uso de Terapia Antirretroviral (TARV). Qual das afirmativas a seguir est√° **INCORRETA** quanto aos objetivos prim√°rios da TARV?",
            "difficulty": "easy",
            "year": "2022-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2022-04-13T01:05:26.000Z",
            "updated_at": "2022-04-13T01:05:26.000Z",
            "user_id": 5227,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 21,
                    "title": "Infectologia",
                    "description": null,
                    "parent_id": 3,
                    "is_enabled": true,
                    "created_at": "2020-05-18T23:32:15.000Z",
                    "updated_at": "2020-05-18T23:32:15.000Z",
                    "pivot": {
                        "discipline_id": 21,
                        "question_id": 13650
                    }
                },
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 13650
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 55929,
                    "question_id": 13650,
                    "description": "Diminuir os n√≠veis plasm√°ticos de RNA do HIV a n√£o detect√°vel.",
                    "explanation": "Errado, Doc! Essa est√° certa. üò¨\n\nO objetivo da TARV √© sim reduzir os n√≠veis de HIV e, para ser mais exato, rezudir para **< 20 a 50 c√≥pias/mL de plasma.**",
                    "order": 0,
                    "correct": false,
                    "created_at": "2022-04-13T01:05:26.000Z",
                    "updated_at": "2022-04-13T01:05:26.000Z",
                    "files": []
                },
                {
                    "id": 55930,
                    "question_id": 13650,
                    "description": "Restabelecer a contagem de CD4 a um n√≠vel normal.",
                    "explanation": "Errado, Doc! Essa est√° certa. üò¨\n\nO HIV √© o **v√≠rus da imunodefici√™ncia humana, ou seja, ele destr√≥i os linf√≥citos CD4** e deixa o organismo sucet√≠vel a doen√ßas oportunistas. Assim, o objetivo da TARV √© sim que o organismo restaure os n√≠veis normais de CD4 e seja capaz de se defender sozinho.",
                    "order": 1,
                    "correct": false,
                    "created_at": "2022-04-13T01:05:26.000Z",
                    "updated_at": "2022-04-13T01:05:26.000Z",
                    "files": []
                },
                {
                    "id": 55931,
                    "question_id": 13650,
                    "description": "Oferecer menos toxicidades ao paciente.",
                    "explanation": "Errado, Doc! Essa est√° certa. üò¨\n\nDurante os anos diversas pesquisas foram feitas com o objetivo de diminuir a toxicidade desses f√°rmacos. **Hoje em dia, a TARV √© recomendada para quase todo paciente pois seus benef√≠cios superam seus riscos!!**",
                    "order": 2,
                    "correct": false,
                    "created_at": "2022-04-13T01:05:26.000Z",
                    "updated_at": "2022-04-13T01:05:26.000Z",
                    "files": []
                },
                {
                    "id": 55932,
                    "question_id": 13650,
                    "description": "Proteger os parceiros do paciente.",
                    "explanation": "Arrasou, Doc!! Essa √© a falsa. ü§ì\n\nA prote√ß√£o dos parceiros n√£o √© o objetivo prim√°rios da TARV, mas sim secund√°rio. O **uso de TARV √© focado no paciente HIV+ e na sua melhora.**",
                    "order": 3,
                    "correct": true,
                    "created_at": "2022-04-13T01:05:26.000Z",
                    "updated_at": "2022-04-13T01:05:26.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 13650,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 991,
            "institution_id": 4,
            "description": "Qual √© o melhor preditor do tempo de progress√£o da infec√ß√£o aguda por HIV para a doen√ßa AIDS?",
            "difficulty": "medium",
            "year": "2020-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:19:46.000Z",
            "updated_at": "2020-06-01T02:19:46.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 991
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4065,
                    "question_id": 991,
                    "description": "CD4",
                    "explanation": "A contagem de CD4 nos ajuda a orientar a terapia e profilaxia para HIV, mas n√£o nos diz sobre a progress√£o de HIV agudo para AIDS",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-05-31T23:19:46.000Z",
                    "updated_at": "2020-05-31T23:19:46.000Z",
                    "files": []
                },
                {
                    "id": 4066,
                    "question_id": 991,
                    "description": "Carga viral",
                    "explanation": "A carga viral sozinha n√£o consegue estimar a progress√£o da doen√ßa. Mas na sua evolu√ß√£o, no ponto em que ela estabiliza, √© um marcador importante de progress√£o para AIDS. Confira o coment√°rio na alternativa correta.",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:19:46.000Z",
                    "updated_at": "2020-05-31T23:19:46.000Z",
                    "files": []
                },
                {
                    "id": 4067,
                    "question_id": 991,
                    "description": "p24",
                    "explanation": "p24 √© um bom marcador para infec√ß√£o aguda, j√° que positiva com 10 dias p√≥s cont√°gio, mas n√£o √© um bom preditor de progress√£o para doen√ßa",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T23:19:46.000Z",
                    "updated_at": "2020-05-31T23:19:46.000Z",
                    "files": []
                },
                {
                    "id": 4068,
                    "question_id": 991,
                    "description": "Set point viral",
                    "explanation": "\n\nSet point viral √© a carga viral que o paciente apresenta quando ocorre a estabiliza√ß√£o da carga viral.\nObserve que em um momento inicial, a carga viral sobe muito, depois ela cai at√© certo ponto e estabiliza. Quanto maior for o valor da carga viral nessa estabiliza√ß√£o (set point viral), mais r√°pida ser√° a progress√£o para AIDS",
                    "order": 3,
                    "correct": true,
                    "created_at": "2020-05-31T23:19:46.000Z",
                    "updated_at": "2021-03-11T01:58:18.000Z",
                    "files": [
                        {
                            "id": 248,
                            "file": "1590966994415.png",
                            "name": "Set-point-viral-load-and-HIV-1-disease-progressionThe-higher-viremia-peak-is-associated.png",
                            "path": "uploads",
                            "type": "image",
                            "subtype": "png",
                            "created_at": "2020-06-01T02:16:35.000Z",
                            "updated_at": "2020-06-01T02:16:35.000Z",
                            "url": "https://qbank.s3.sa-east-1.amazonaws.com/uploads/1590966994415.png",
                            "description": null,
                            "source": null,
                            "overlay_id": null,
                            "user_id": null,
                            "pivot": {
                                "file_id": 248,
                                "alternative_id": 4068
                            }
                        }
                    ]
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 991,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 996,
            "institution_id": 4,
            "description": "Imagine que voc√™ teve uma rela√ß√£o sexual desprotegida. Como voc√™ √© estudante de medicina, sabe que existe uma terapia profilaxia P√≥s-Exposi√ß√£o (PEP) que pode ser iniciada em at√© 72h do contato para evitar que a infec√ß√£o pelo v√≠rus HIV se estabele√ßa, caso ela tenha ocorrido. Assinale a alternativa que contenha o esquema da PEP:",
            "difficulty": "medium",
            "year": "2019-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:38:30.000Z",
            "updated_at": "2020-10-01T23:31:04.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 996
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4086,
                    "question_id": 996,
                    "description": "Tenofovir (TDC) + Lamivudina (3TC) + Dolutegravir",
                    "explanation": "Perfeito. √â a mesma medica√ß√£o de primeira escolha para o tratamento do HIV. Por√©m, ela s√≥ √© administrada por 28 dias.",
                    "order": 0,
                    "correct": true,
                    "created_at": "2020-05-31T23:38:31.000Z",
                    "updated_at": "2020-10-01T20:31:04.000Z",
                    "files": []
                },
                {
                    "id": 4087,
                    "question_id": 996,
                    "description": "Tenofovir (TDC) + Entricitabina",
                    "explanation": "Esse √© o esquema para a PrEP (Profilaxia Pr√©-Exposi√ß√£o), e n√£o da PEP",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:38:31.000Z",
                    "updated_at": "2020-10-01T20:31:04.000Z",
                    "files": []
                },
                {
                    "id": 4088,
                    "question_id": 996,
                    "description": "Tenofovir (TDC) + Lamivudina (3TC) + Efavirenz",
                    "explanation": "O efavirenz n√£o faz parte da PEP",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T23:38:31.000Z",
                    "updated_at": "2020-10-01T20:31:04.000Z",
                    "files": []
                },
                {
                    "id": 4089,
                    "question_id": 996,
                    "description": "Nenhuma das alternativas acima",
                    "explanation": "Lembre que a PEP √© a mesma do tratamento para indiv√≠duos infectados com HIV, mas apenas por 28 dias",
                    "order": 3,
                    "correct": false,
                    "created_at": "2020-05-31T23:38:31.000Z",
                    "updated_at": "2020-10-01T20:31:04.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 996,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 997,
            "institution_id": 4,
            "description": "A Profilaxia Pr√©-Exposi√ß√£o (PrEP) ao HIV √© um novo m√©todo de preven√ß√£o √† infec√ß√£o pelo HIV. A PrEP consiste na tomada di√°ria de um comprimido que impede que o v√≠rus causador da aids infecte o organismo, antes de a pessoa ter contato com o v√≠rus.¬†Assinale a alternativa que contenha as medica√ß√µes do PrEP: ",
            "difficulty": "medium",
            "year": "2019-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:43:11.000Z",
            "updated_at": "2021-07-13T23:36:47.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 997
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4090,
                    "question_id": 997,
                    "description": "Lamivudina e Dolutegravir",
                    "explanation": "Nenhuma dessas medica√ß√µes faz parte da PrEP",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-05-31T23:43:11.000Z",
                    "updated_at": "2021-07-13T20:36:47.000Z",
                    "files": []
                },
                {
                    "id": 4091,
                    "question_id": 997,
                    "description": "Tenofovir + Lamivudina + Efavirenz",
                    "explanation": "Desses medicamentos, apenas o Tenofovir faz parte da PrEP",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:43:11.000Z",
                    "updated_at": "2021-07-13T20:36:47.000Z",
                    "files": []
                },
                {
                    "id": 4092,
                    "question_id": 997,
                    "description": "Tenofovir + Lamivudina + Dolutegravir",
                    "explanation": "Essas s√£o as medica√ß√µes usadas na PEP e no tratamento de indiv√≠duos com HIV",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T23:43:11.000Z",
                    "updated_at": "2021-07-13T20:36:47.000Z",
                    "files": []
                },
                {
                    "id": 4093,
                    "question_id": 997,
                    "description": "Tenofovir + emtricitabina",
                    "explanation": "A PrEP √© a combina√ß√£o de dois medicamentos (tenofovir + emtricitabina) que bloqueiam alguns ‚Äúcaminhos‚Äù que o HIV usa para infectar seu organismo. Se voc√™ tomar PrEP diariamente, a medica√ß√£o pode impedir que o HIV se estabele√ßa e se espalhe em seu corpo.\nEla te protege ap√≥s 7 dias de uso para rela√ß√£o anal e 20 dias de uso para rela√ß√£o vaginal.¬† \nEla √© indicada para os seguintes grupos:\nGays e outros homens que fazem sexo com homens (HSH);¬† Pessoas trans;¬† Trabalhadores(as) do sexo;. Frequentemente deixa de usar camisinha em suas rela√ß√µes sexuais (anais ou vaginais); Tem rela√ß√µes sexuais, sem camisinha, com algu√©m que seja HIV positivo e que n√£o esteja em tratamento; Faz uso repetido de PEP (Profilaxia P√≥s-Exposi√ß√£o ao HIV) ou apresenta epis√≥dios frequentes de Infec√ß√µes Sexualmente Transmiss√≠veis ",
                    "order": 3,
                    "correct": true,
                    "created_at": "2020-05-31T23:43:11.000Z",
                    "updated_at": "2021-07-13T20:36:47.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 997,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 998,
            "institution_id": 1,
            "description": "Assinale a alternativa **CORRETA** em rela√ß√£o √† toxoplasmose cerebral em pessoa vivendo com HIV (PVHIV).",
            "difficulty": "medium",
            "year": "2018-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:49:34.000Z",
            "updated_at": "2022-06-28T23:00:00.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 1,
                "title": "UFSC",
                "state": "Santa Catarina",
                "is_enabled": true,
                "created_at": "2020-05-16T20:39:39.000Z",
                "updated_at": "2020-05-16T20:39:39.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 998
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4094,
                    "question_id": 998,
                    "description": "A toxoplasmose √© a terceira causa mais comum de les√µes expansivas em PVHIV.",
                    "explanation": "Essa est√° incorreta, Doc! üôä A toxoplasmose √© a causa mais comum de les√µes expansivas cerebrais em PVHIV",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-05-31T23:49:34.000Z",
                    "updated_at": "2022-06-28T23:00:00.000Z",
                    "files": []
                },
                {
                    "id": 4095,
                    "question_id": 998,
                    "description": "Ao longo do tratamento, a resposta radiol√≥gica costuma preceder a resposta cl√≠nica.",
                    "explanation": "Essa est√° incorreta, Doc! üôä Normalmente a melhora cl√≠nica vem antes da melhora radiol√≥gica, ou seja, o paciente fica bem clinicamente, mas a imagem de raio X continua mostrando les√µes.",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:49:34.000Z",
                    "updated_at": "2022-06-28T23:00:00.000Z",
                    "files": []
                },
                {
                    "id": 4096,
                    "question_id": 998,
                    "description": "Pacientes com esse diagn√≥stico geralmente apresentam contagem de linf√≥citos T CD4+ abaixo de 100 c√©ls/mm¬≥.",
                    "explanation": "Est√° correto, Doc! Perfeito! üòç Os pacientes que possuem CD4 < 200 fazem profilaxia com sulfametoxazol + trimetroprim para preven√ß√£o de pneumocistose. Por√©m, essa profilaxia j√° protege tamb√©m para neurotoxoplasmose.",
                    "order": 2,
                    "correct": true,
                    "created_at": "2020-05-31T23:49:35.000Z",
                    "updated_at": "2022-06-28T23:00:00.000Z",
                    "files": []
                },
                {
                    "id": 4097,
                    "question_id": 998,
                    "description": "A resson√¢ncia magn√©tica de cr√¢nio √© o exame diagn√≥stico de imagem de escolha na rede p√∫blica do SUS..",
                    "explanation": "Essa est√° incorreta, Doc! üôä A TC de cr√¢nio √© o exame de escolha no SUS. A imagem cl√°ssica s√£o imagens com realce anelar na TC.",
                    "order": 3,
                    "correct": false,
                    "created_at": "2020-05-31T23:49:35.000Z",
                    "updated_at": "2022-06-28T23:00:00.000Z",
                    "files": []
                },
                {
                    "id": 4098,
                    "question_id": 998,
                    "description": "O tratamento de escolha para pacientes n√£o al√©rgicos ou intolerantes √† sulfa √© a associa√ß√£o de sulfadiazina, pirimetamina e √°cido fol√≠nico por quatro semanas.",
                    "explanation": "Essa est√° incorreta, Doc! Pegadinha! üôäO tempo √© de 6 semanas, e n√£o 4 semanas",
                    "order": 4,
                    "correct": false,
                    "created_at": "2020-05-31T23:49:35.000Z",
                    "updated_at": "2022-06-28T23:00:00.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 998,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 999,
            "institution_id": 5,
            "description": "Assinale a alternativa com crit√©rio(s) que define(m) o diagn√≥stico de S√≠ndrome da Imunodefici√™ncia Adquirida (SIDA) em pacientes sintom√°ticos.",
            "difficulty": "medium",
            "year": "2015-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T02:52:54.000Z",
            "updated_at": "2020-06-01T02:52:54.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 5,
                "title": "AMRIGS",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-17T13:59:53.000Z",
                "updated_at": "2020-05-17T13:59:53.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 999
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4099,
                    "question_id": 999,
                    "description": "Infec√ß√£o pelo HIV e contagem de CD4+ <200/ŒºL.",
                    "explanation": "Perfeito. Quest√£o conceitual. Poder√≠amos acrescentar aqui, ainda, independente da contagem de CD4, se o indiv√≠duo apresentar infec√ß√£o por doen√ßa oportunista consideramos AIDS tamb√©m.",
                    "order": 0,
                    "correct": true,
                    "created_at": "2020-05-31T23:52:54.000Z",
                    "updated_at": "2020-05-31T23:52:54.000Z",
                    "files": []
                },
                {
                    "id": 4100,
                    "question_id": 999,
                    "description": "Infec√ß√£o pelo HIV e contagem de CD4+ <300/ŒºL.",
                    "explanation": "Quest√£o conceitual. Para caracterizar a AIDS, precisamos que o indiv√≠duo possua o v√≠rus e apresente algum marcador de que sua imunidade est√° comprometida",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-05-31T23:52:54.000Z",
                    "updated_at": "2020-05-31T23:52:54.000Z",
                    "files": []
                },
                {
                    "id": 4101,
                    "question_id": 999,
                    "description": "Infec√ß√£o pelo HIV e contagem de CD4+ <400/ŒºL.",
                    "explanation": "Quest√£o conceitual. Para caracterizar a AIDS, precisamos que o indiv√≠duo possua o v√≠rus e apresente algum marcador de que sua imunidade est√° comprometida ",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-05-31T23:52:54.000Z",
                    "updated_at": "2020-05-31T23:52:54.000Z",
                    "files": []
                },
                {
                    "id": 4102,
                    "question_id": 999,
                    "description": "Apenas a contagem de CD4+ <300/ŒºL.",
                    "explanation": "Quest√£o conceitual. Para caracterizar a AIDS, precisamos que o indiv√≠duo possua o v√≠rus e apresente algum marcador de que sua imunidade est√° comprometida ",
                    "order": 3,
                    "correct": false,
                    "created_at": "2020-05-31T23:52:54.000Z",
                    "updated_at": "2020-05-31T23:52:54.000Z",
                    "files": []
                },
                {
                    "id": 4103,
                    "question_id": 999,
                    "description": "Apenas a detec√ß√£o de infec√ß√£o pelo HIV.",
                    "explanation": "Quest√£o conceitual. Para caracterizar a AIDS, precisamos que o indiv√≠duo possua o v√≠rus e apresente algum marcador de que sua imunidade est√° comprometida ",
                    "order": 4,
                    "correct": false,
                    "created_at": "2020-05-31T23:52:54.000Z",
                    "updated_at": "2020-05-31T23:52:54.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 999,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 1001,
            "institution_id": 26,
            "description": "Sobre a s√≠ndrome de imunodefici√™ncia adquirida (AIDS), √© CORRETO afirmar que:",
            "difficulty": "medium",
            "year": "2015-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T03:05:22.000Z",
            "updated_at": "2021-07-06T15:55:15.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 26,
                "title": "UEPA",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-18T19:57:18.000Z",
                "updated_at": "2020-05-18T19:57:18.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 1001
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4109,
                    "question_id": 1001,
                    "description": "acometimento dermatol√≥gico √© raro na s√≠ndrome de soroconvers√£o.",
                    "explanation": "At√© 50% apresentam hash na apresenta√ß√£o da infec√ß√£o aguda",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-06-01T00:05:22.000Z",
                    "updated_at": "2021-07-06T12:55:15.000Z",
                    "files": []
                },
                {
                    "id": 4110,
                    "question_id": 1001,
                    "description": "les√µes dermatol√≥gicas extensas, dolorosas, ulceradas, com mais de 30 dias, localizadas geralmente em regi√µes anorretais e genitais est√£o associadas √† infec√ß√£o secud√°ria pelo HPV.",
                    "explanation": "O HPV tem como les√£o caracter√≠stica as verrugas. Essa descri√ß√£o se refere √†s les√µes por citomegalov√≠rus ou herpes nesses pacientes",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-06-01T00:05:22.000Z",
                    "updated_at": "2021-07-06T12:55:15.000Z",
                    "files": []
                },
                {
                    "id": 4111,
                    "question_id": 1001,
                    "description": "infec√ß√µes bacterianas como a norcardiose, salmoneloses disseminadas e micobacterioses at√≠picas como as causadas pelo Mycobacterium leprae s√£o infec√ß√µes oportunistas cl√°ssicas definidoras de AIDS",
                    "explanation": "Mycobacterium leprae casa hansen√≠ase, e n√£o micobacterioses at√≠picas",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-06-01T00:05:22.000Z",
                    "updated_at": "2021-07-06T12:55:15.000Z",
                    "files": []
                },
                {
                    "id": 4112,
                    "question_id": 1001,
                    "description": "linfomas relacionados √† aids podem ser divididos, de acordo com sua localiza√ß√£o, em 3 grupos distintos: sist√™micos, prim√°rio do sistema nervoso central, linfomas das cavidades corporais.",
                    "explanation": "Perfeito. Os linfomas prim√°rios do sistema nervoso central acabam sendo mais encontrados em pacientes com CD4 menor que 100. Os demais linfomas podem aparecer independente da contagem de CD4.",
                    "order": 3,
                    "correct": true,
                    "created_at": "2020-06-01T00:05:22.000Z",
                    "updated_at": "2021-07-06T12:55:15.000Z",
                    "files": []
                },
                {
                    "id": 4113,
                    "question_id": 1001,
                    "description": "o HIV √© a causa viral prim√°ria e preponderante do sarcoma de Kaposi associado √† AIDS.",
                    "explanation": "A causa prim√°ria do sarcoma de Kaposi √© o herpes v√≠rus tipo 8. O HIV facilita o estabelecimento da infec√ß√£o desse v√≠rus.",
                    "order": 4,
                    "correct": false,
                    "created_at": "2020-06-01T00:05:22.000Z",
                    "updated_at": "2021-07-06T12:55:15.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 1001,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 1002,
            "institution_id": 67,
            "description": "Em rela√ß√£o √† coinfec√ß√£o HIV/Tuberculose Pulmonar (TBP), assinale a alternativa CORRETA:",
            "difficulty": "medium",
            "year": "2016-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2020-06-01T03:12:27.000Z",
            "updated_at": "2020-06-01T03:12:27.000Z",
            "user_id": 108,
            "is_residency": false,
            "institution": {
                "id": 67,
                "title": "UERN",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-24T03:38:41.000Z",
                "updated_at": "2020-05-24T03:38:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 1002
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 4114,
                    "question_id": 1002,
                    "description": "Deve-se iniciar tratamento simult√¢neo das duas condi√ß√µes. Optar por esquema antirretroviral sem inibidores de protease.",
                    "explanation": "N√£o devemos iniciar os tratamentos simultaneamente",
                    "order": 0,
                    "correct": false,
                    "created_at": "2020-06-01T00:12:27.000Z",
                    "updated_at": "2020-06-01T00:12:27.000Z",
                    "files": []
                },
                {
                    "id": 4115,
                    "question_id": 1002,
                    "description": "Deve-se realizar o Tratamento Antirretroviral (TARV) inicialmente. A atividade da tuberculose pulmonar tende a recrudescer ap√≥s o in√≠cio da TARV.",
                    "explanation": "Primeiro iniciamos com o tratamento para TBP",
                    "order": 1,
                    "correct": false,
                    "created_at": "2020-06-01T00:12:27.000Z",
                    "updated_at": "2020-06-01T00:12:27.000Z",
                    "files": []
                },
                {
                    "id": 4116,
                    "question_id": 1002,
                    "description": "Iniciar a TARV ap√≥s o t√©rmino do tratamento para TBP; a intera√ß√£o das drogas utilizadas apresenta efeitos colaterais proibitivos para a associa√ß√£o dos esquemas.",
                    "explanation": "Inicia-se a TARV ap√≥s 2 semanas a 2 meses do in√≠cio do tratamento para TBP",
                    "order": 2,
                    "correct": false,
                    "created_at": "2020-06-01T00:12:27.000Z",
                    "updated_at": "2020-06-01T00:12:27.000Z",
                    "files": []
                },
                {
                    "id": 4117,
                    "question_id": 1002,
                    "description": "Iniciar a TARV ap√≥s 30 dias do in√≠cio da poliquimioterapia para tratamento da tuberculose pulmonar. Esta, quando em atividade, est√° associada diretamente √† diminui√ß√£o dos linf√≥citos CD4.",
                    "explanation": "Os tratamentos n√£o devem ser iniciados juntos, pois h√° aumento da s√≠ndrome de resconstitui√ß√£o imune, o que leva o paciente ao risco de morte pela recupera√ß√£o da resposta inflamat√≥ria e piora dos sintomas da tuberculose. \nLogo, primeiro inicia o tratamento de tuberculose e entre 2 semanas e 2 meses inicia-se o tratamento para HIV.",
                    "order": 3,
                    "correct": true,
                    "created_at": "2020-06-01T00:12:27.000Z",
                    "updated_at": "2020-06-01T00:12:27.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 1002,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 13645,
            "institution_id": 4,
            "description": "Suponhamos que um **paciente HIV+** chegue em seu consult√≥rio acompanhado de sua atual namorada. Qual das alternativas abaixo √© a **CORRETA** sobre as condutas que devem ser tomadas em rela√ß√£o a namorada?",
            "difficulty": "medium",
            "year": "2022-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2022-04-13T00:30:51.000Z",
            "updated_at": "2022-04-13T00:30:51.000Z",
            "user_id": 5227,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 13645
                    }
                },
                {
                    "id": 21,
                    "title": "Infectologia",
                    "description": null,
                    "parent_id": 3,
                    "is_enabled": true,
                    "created_at": "2020-05-18T23:32:15.000Z",
                    "updated_at": "2020-05-18T23:32:15.000Z",
                    "pivot": {
                        "discipline_id": 21,
                        "question_id": 13645
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 55908,
                    "question_id": 13645,
                    "description": "Iniciar imediatamente profilaxia pr√©-exposi√ß√£o (PrEP).",
                    "explanation": "Falso, Doc! ü•¥\n\nA PrEP s√≥ pode ser usada ap√≥s testes r√°pidos regulares negativos. Al√©m disso, **antes de inicar o uso de PrEP** pela namorada seria necess√°rio que ela **fizesse o uso de PEP por 28 dias.**",
                    "order": 0,
                    "correct": false,
                    "created_at": "2022-04-13T00:30:51.000Z",
                    "updated_at": "2022-04-13T00:30:51.000Z",
                    "files": []
                },
                {
                    "id": 55909,
                    "question_id": 13645,
                    "description": "Informar que n√£o h√° qualquer interven√ß√£o medicamentosa a ser adotada no momento e que eles devem usar preservativo nas rela√ß√µes sexuais.",
                    "explanation": "Falso, Doc! ü•¥\n\nA maior preven√ß√£o para o HIV √© sim o uso de preservativo, mas **n√£o podemos descartar a possibilidade de transmiss√£o atrav√©s de outros meios**, como o compartilhamento de objetos perfuro cortantes. Al√©m disso, **existem sim interven√ß√µes medicamentosas!!**",
                    "order": 1,
                    "correct": false,
                    "created_at": "2022-04-13T00:30:51.000Z",
                    "updated_at": "2022-04-13T00:30:51.000Z",
                    "files": []
                },
                {
                    "id": 55910,
                    "question_id": 13645,
                    "description": "Iniciar imediatamente profilaxia p√≥s-exposi√ß√£o (PEP).",
                    "explanation": "Falso, Doc! ü•¥\n\n**N√£o podemos fazer isso** pois n√£o sabemos se a namorada j√° n√£o √© HIV positiva!! **A PEP deve ser administrada de modo profil√°tico em casos de pessoas HIV negativas.**",
                    "order": 2,
                    "correct": false,
                    "created_at": "2022-04-13T00:30:51.000Z",
                    "updated_at": "2022-04-13T00:30:51.000Z",
                    "files": []
                },
                {
                    "id": 55911,
                    "question_id": 13645,
                    "description": "Realizar imediatamente o teste r√°pido do HIV. Caso seja negativo, deve-se prescrever a PEP (se √∫ltima rela√ß√£o desprotegida h√° menos de 72 horas) e repetir o teste em tr√™s semanas.",
                    "explanation": "Arrasou, Doc!! üòú\n\nE n√£o vamos esquecer que **devemos instruir nossos pacientes a usarem preservativos em TODAS as rela√ß√µes sexuais** e evitar o compartilhamento de objetos perfuro cortantes.",
                    "order": 3,
                    "correct": true,
                    "created_at": "2022-04-13T00:30:51.000Z",
                    "updated_at": "2022-04-13T00:30:51.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 13645,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 13651,
            "institution_id": 4,
            "description": "Para reduzir a replica√ß√£o do HIV √© preciso a combina√ß√£o de 2, 3 ou 4 f√°rmacos de clases diferentes. Qual das afirmativas a seguir √© **INCORRETA** para os crit√©rios de escolha das combina√ß√µes?",
            "difficulty": "medium",
            "year": "2022-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2022-04-13T01:39:36.000Z",
            "updated_at": "2022-04-13T01:39:36.000Z",
            "user_id": 5227,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 21,
                    "title": "Infectologia",
                    "description": null,
                    "parent_id": 3,
                    "is_enabled": true,
                    "created_at": "2020-05-18T23:32:15.000Z",
                    "updated_at": "2020-05-18T23:32:15.000Z",
                    "pivot": {
                        "discipline_id": 21,
                        "question_id": 13651
                    }
                },
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 13651
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 55933,
                    "question_id": 13651,
                    "description": "Efeitos adversos previstos.",
                    "explanation": "Poxa, Doc, essa √© correta! ü§®\n\n**O paciente precisa participar da escolha dos medicamentos** que vai usar e saber dos efeitos adversos √© um dos passos para a ader√™ncia correta ao tratamento. Ent√£o, efeitos adversos s√£o levados em considera√ß√£o da escolha das combina√ß√µes!",
                    "order": 0,
                    "correct": false,
                    "created_at": "2022-04-13T01:39:36.000Z",
                    "updated_at": "2022-04-13T01:39:36.000Z",
                    "files": []
                },
                {
                    "id": 55934,
                    "question_id": 13651,
                    "description": "Doen√ßas concomitantes.",
                    "explanation": "Poxa, Doc, essa √© correta! ü§®\n\nAs doen√ßas concomitantes podem j√° estar gerando disfun√ß√µes em outros sistemas, ent√£o a escolha de um rem√©dio que n√£o piore-as √© imprescind√≠vel.",
                    "order": 1,
                    "correct": false,
                    "created_at": "2022-04-13T01:39:36.000Z",
                    "updated_at": "2022-04-13T01:39:36.000Z",
                    "files": []
                },
                {
                    "id": 55935,
                    "question_id": 13651,
                    "description": "Complexidade dos esquemas.",
                    "explanation": "Arrasou, Doc, essa √© a errada!! üí™\n\nNa verdade, o crit√©rio de escolha **preza pela SIMPLICIDADE dos esquemas.** A ades√£o ao tratamento √© aumentada quando as dosagens s√£o apenas uma vez ao dia, preferencialmente!",
                    "order": 2,
                    "correct": true,
                    "created_at": "2022-04-13T01:39:36.000Z",
                    "updated_at": "2022-04-13T01:39:36.000Z",
                    "files": []
                },
                {
                    "id": 55936,
                    "question_id": 13651,
                    "description": "Intera√ß√µes medicamentosas.",
                    "explanation": "Poxa, Doc, essa √© correta! ü§®\n\nO **uso de outros f√°rmacos podem aumentar ou diminuir a efic√°cia da TARV**, ent√£o √© preciso muita aten√ß√£o na prescri√ß√£o.",
                    "order": 3,
                    "correct": false,
                    "created_at": "2022-04-13T01:39:36.000Z",
                    "updated_at": "2022-04-13T01:39:36.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 13651,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 13653,
            "institution_id": 4,
            "description": "A Profilaxia Pr√©-Exposi√ß√£o (PrEP) e Profilaxia P√≥s-Exposi√ß√£o (PEP) s√£o drogas usadas para o preven√ß√£o do HIV. Com base nisso, qual das alternativas abaixo corresponde **CORRETAMENTE** ao esquema de uso da PrEP e PEP, respectivamente?",
            "difficulty": "medium",
            "year": "2022-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2022-04-13T12:54:47.000Z",
            "updated_at": "2022-04-13T12:54:47.000Z",
            "user_id": 5227,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 21,
                    "title": "Infectologia",
                    "description": null,
                    "parent_id": 3,
                    "is_enabled": true,
                    "created_at": "2020-05-18T23:32:15.000Z",
                    "updated_at": "2020-05-18T23:32:15.000Z",
                    "pivot": {
                        "discipline_id": 21,
                        "question_id": 13653
                    }
                },
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 13653
                    }
                },
                {
                    "id": 172,
                    "title": "Farmacologia",
                    "description": null,
                    "parent_id": 1,
                    "is_enabled": true,
                    "created_at": "2020-06-09T16:52:36.000Z",
                    "updated_at": "2020-06-09T16:52:36.000Z",
                    "pivot": {
                        "discipline_id": 172,
                        "question_id": 13653
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 55941,
                    "question_id": 13653,
                    "description": "Uso ininterrupto - 28 dias.",
                    "explanation": "Arrasou, Doc!! üòç\n\nEsse √© o **esquema correto** de uso desses medicamento:\n- PrEP: uso ininterrupto;\n- PEP: 28 dias.\n\nFonte da Imagem: http://www.aids.gov.br/sites/default/files/pub/2018/66234/diferenca_prep_pep_08_2018.jpg",
                    "order": 0,
                    "correct": true,
                    "created_at": "2022-04-13T12:54:47.000Z",
                    "updated_at": "2022-04-13T12:54:47.000Z",
                    "files": [
                        {
                            "id": 34058,
                            "file": "4f8e977b-e2e1-46fb-ae8d-b75e55021659.jpeg",
                            "name": "diferenca_prep_pep_08_2018.jpg",
                            "path": "uploads",
                            "type": "image",
                            "subtype": "jpeg",
                            "created_at": "2022-04-13T12:54:13.000Z",
                            "updated_at": "2022-04-13T12:54:13.000Z",
                            "url": "https://qbank.s3.sa-east-1.amazonaws.com/uploads/4f8e977b-e2e1-46fb-ae8d-b75e55021659.jpeg",
                            "description": null,
                            "source": null,
                            "overlay_id": null,
                            "user_id": null,
                            "pivot": {
                                "file_id": 34058,
                                "alternative_id": 55941
                            }
                        }
                    ]
                },
                {
                    "id": 55942,
                    "question_id": 13653,
                    "description": "28 dias - Uso ininterrupto.",
                    "explanation": "Falso, Doc! üòñ\n\nEsse √© o **esquema correto** de uso desses medicamento:\n- PrEP: uso ininterrupto;\n- PEP: 28 dias.",
                    "order": 1,
                    "correct": false,
                    "created_at": "2022-04-13T12:54:47.000Z",
                    "updated_at": "2022-04-13T12:54:47.000Z",
                    "files": []
                },
                {
                    "id": 55943,
                    "question_id": 13653,
                    "description": "30 dias - Uso ininterrupto.",
                    "explanation": "Falso, Doc! üòñ\n\nEsse √© o **esquema correto** de uso desses medicamento:\n- PrEP: uso ininterrupto;\n- PEP: 28 dias.",
                    "order": 2,
                    "correct": false,
                    "created_at": "2022-04-13T12:54:47.000Z",
                    "updated_at": "2022-04-13T12:54:47.000Z",
                    "files": []
                },
                {
                    "id": 55944,
                    "question_id": 13653,
                    "description": "Uso ininterrupto - 30 dias.",
                    "explanation": "Falso, Doc! üòñ\n\nEsse √© o **esquema correto** de uso desses medicamento:\n- PrEP: uso ininterrupto;\n- PEP: 28 dias.",
                    "order": 3,
                    "correct": false,
                    "created_at": "2022-04-13T12:54:47.000Z",
                    "updated_at": "2022-04-13T12:54:47.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 13653,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 7724,
            "institution_id": 300,
            "description": "S√£o muitas as vantagens da amamenta√ß√£o para a crian√ßa, a m√£e, a fam√≠lia e a sociedade. Segundo a OMS, a pr√°tica da amamenta√ß√£o atualmente resguarda a sa√∫de de 6 milh√µes de crian√ßas a cada ano, prevenindo diarreia e infec√ß√µes respirat√≥rias agudas. Sabe-se que crian√ßas que n√£o s√£o amamentadas com leite materno apresentam maior riso de √≥bito por diarreia (risco 14,2 vezes maior), doen√ßas respirat√≥rias (3,6 vezes) e outros tipos de infec√ß√µes, quando comparadas √†quelas que recebem aleitamento materno exclusivo. \n\n\nNas situa√ß√µes abaixo, assinale quais possuem CONTRAINDICA√á√ÉO ABSOLUTA ao aleitamento materno a marque a alternativa com a sequ√™ncia correta:  \n- ( ) Portadora HIV \n- ( ) Portadora Herpes (sem infec√ß√£o ativa) \n- ( ) Portadora HTLV1 \n- ( ) Usu√°ria Coca√≠na inalat√≥ria. \n- ( ) Usu√°ria de Tamoxifeno \n- ( ) Usu√°ria de benzodiazep√≠nicos  \n",
            "difficulty": "hard",
            "year": "2016-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2021-05-04T17:33:43.000Z",
            "updated_at": "2022-04-02T20:13:14.000Z",
            "user_id": 1475,
            "is_residency": true,
            "institution": {
                "id": 300,
                "title": "Universidade Federal de Roraima",
                "state": null,
                "is_enabled": true,
                "created_at": "2021-05-04T14:33:43.000Z",
                "updated_at": "2021-05-04T14:33:43.000Z"
            },
            "disciplines": [
                {
                    "id": 712,
                    "title": "Herpes Genital",
                    "description": null,
                    "parent_id": 447,
                    "is_enabled": true,
                    "created_at": "2021-05-04T17:07:08.000Z",
                    "updated_at": "2021-05-04T17:07:08.000Z",
                    "pivot": {
                        "discipline_id": 712,
                        "question_id": 7724
                    }
                },
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 7724
                    }
                },
                {
                    "id": 77,
                    "title": "Infec√ß√µes Cong√™nitas",
                    "description": null,
                    "parent_id": 28,
                    "is_enabled": true,
                    "created_at": "2020-05-27T23:13:46.000Z",
                    "updated_at": "2020-06-14T17:06:12.000Z",
                    "pivot": {
                        "discipline_id": 77,
                        "question_id": 7724
                    }
                },
                {
                    "id": 979,
                    "title": "Aleitamento Materno",
                    "description": null,
                    "parent_id": 808,
                    "is_enabled": true,
                    "created_at": "2021-09-26T17:17:59.000Z",
                    "updated_at": "2021-09-26T17:17:59.000Z",
                    "pivot": {
                        "discipline_id": 979,
                        "question_id": 7724
                    }
                },
                {
                    "id": 80,
                    "title": "Aleitamento \t\t",
                    "description": null,
                    "parent_id": 160,
                    "is_enabled": true,
                    "created_at": "2020-05-28T00:41:52.000Z",
                    "updated_at": "2020-06-07T05:56:39.000Z",
                    "pivot": {
                        "discipline_id": 80,
                        "question_id": 7724
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 31719,
                    "question_id": 7724,
                    "description": "N√ÉO, N√ÉO, SIM, SIM, SIM e SIM ",
                    "explanation": "Falso, Doc! üëÄ Confira a explica√ß√£o completa no coment√°rio da alternativa correta üòâ",
                    "order": 0,
                    "correct": false,
                    "created_at": "2021-05-04T14:33:43.000Z",
                    "updated_at": "2022-04-02T20:13:14.000Z",
                    "files": []
                },
                {
                    "id": 31720,
                    "question_id": 7724,
                    "description": "SIM, N√ÉO, SIM, SIM, SIM e N√ÉO ",
                    "explanation": "Fera demais, DOc! üôÄ Bora ver as alternativas?\n\n- **HIV**: pode ser transmitido pelo aleitamento materno\n- **Herpes**: n√£o pode ser transmitida pelo aleitamento materno - Lembre-se que vimos que o herpes permanece no nervo para o qual se instalou e s√≥ recidiva no mesmo local \n- **HTLV-1**: pode ser transmitido pelo aleitamento materno\n- **Coca√≠na inalat√≥ria**: pode ter toxicidade pelo aleitamento materno\n- **Tamoxifeno**: n√£o se sabe se √© eliminado no leite, mas pelo risco potencial de efeitos adversos na crian√ßa, o aleitamento materno √© contraindicado quando o est√° usando\n- **Benzodiazep√≠nicos**: apesar de seu efeito sedativo no lactente, n√£o √© uma contraindica√ß√£o absoluta, mas recomenda-se cautela.  ",
                    "order": 1,
                    "correct": true,
                    "created_at": "2021-05-04T14:33:43.000Z",
                    "updated_at": "2022-04-02T20:13:14.000Z",
                    "files": []
                },
                {
                    "id": 31721,
                    "question_id": 7724,
                    "description": "SIM, SIM, SIM, N√ÉO, SIM e SIM ",
                    "explanation": "Falso, Doc! üëÄ Confira a explica√ß√£o completa no coment√°rio da alternativa correta üòâ ",
                    "order": 2,
                    "correct": false,
                    "created_at": "2021-05-04T14:33:43.000Z",
                    "updated_at": "2022-04-02T20:13:14.000Z",
                    "files": []
                },
                {
                    "id": 31722,
                    "question_id": 7724,
                    "description": "SIM, N√ÉO, N√ÉO, SIM, N√ÉO e N√ÉO",
                    "explanation": "Falso, Doc! üëÄ Confira a explica√ß√£o completa no coment√°rio da alternativa correta üòâ ",
                    "order": 3,
                    "correct": false,
                    "created_at": "2021-05-04T14:33:43.000Z",
                    "updated_at": "2022-04-02T20:13:14.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 7724,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 12706,
            "institution_id": 4,
            "description": "Um homem de 35 anos, HIV positivo aderente a TARV, se apresenta ao servi√ßo de emerg√™ncia com n√°useas, v√¥mitos e dores em flanco. Sua creatinina no momento √© 2,9 mg/dL, mas h√° duas semanas apresentava creatinina de 0,8 mg/dl. √Ä microscopia de urina apresenta cristais em formato de agulha e em formato retangular. \nDentre as seguintes medica√ß√µes, qual a causadora mais prov√°vel da IRA desse paciente?",
            "difficulty": "hard",
            "year": "2021-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2022-02-10T23:16:10.000Z",
            "updated_at": "2022-02-11T19:58:52.000Z",
            "user_id": 2296,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 190,
                    "title": "Inj√∫ria Renal Aguda\t\t",
                    "description": null,
                    "parent_id": 189,
                    "is_enabled": true,
                    "created_at": "2020-06-11T20:16:32.000Z",
                    "updated_at": "2020-06-11T20:16:32.000Z",
                    "pivot": {
                        "discipline_id": 190,
                        "question_id": 12706
                    }
                },
                {
                    "id": 189,
                    "title": "Nefrologia",
                    "description": null,
                    "parent_id": 3,
                    "is_enabled": true,
                    "created_at": "2020-06-11T20:16:05.000Z",
                    "updated_at": "2020-06-11T20:16:05.000Z",
                    "pivot": {
                        "discipline_id": 189,
                        "question_id": 12706
                    }
                },
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 12706
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 52135,
                    "question_id": 12706,
                    "description": "Zidovudina.",
                    "explanation": "Errado doc! O efeito colateral mais proeminente da zidovudina √© a mielossupress√£o, que pode cursar com anemia e leucopenia. N√£o cursa com cristal√∫ria.",
                    "order": 0,
                    "correct": false,
                    "created_at": "2022-02-10T23:16:10.000Z",
                    "updated_at": "2022-02-11T19:58:52.000Z",
                    "files": []
                },
                {
                    "id": 52136,
                    "question_id": 12706,
                    "description": "Ritonavir.",
                    "explanation": "BOA DOC! üòÅ Quest√£o dif√≠cil essa. A forma√ß√£o de cristais na urina √© cl√°ssica do ritonavir, um inibidor de protease utilizado no tratamento do HIV. Ele aumenta as chances de IRA e forma√ß√£o de c√°lculos renais.",
                    "order": 1,
                    "correct": true,
                    "created_at": "2022-02-10T23:16:10.000Z",
                    "updated_at": "2022-02-11T19:58:52.000Z",
                    "files": []
                },
                {
                    "id": 52137,
                    "question_id": 12706,
                    "description": "Efavirenz.",
                    "explanation": "Falso doc! O efeito colateral mais marcante do efavirenz √© o padr√£o anormal de sonhos, descrito por v√°rios pacientes. Esse medicamento n√£o causa cristal√∫ria.",
                    "order": 2,
                    "correct": false,
                    "created_at": "2022-02-10T23:16:10.000Z",
                    "updated_at": "2022-02-11T19:58:52.000Z",
                    "files": []
                },
                {
                    "id": 52138,
                    "question_id": 12706,
                    "description": "Maraviroc.",
                    "explanation": "Incorreto doc. Os efeitos adversos do maraviroc s√£o inespec√≠ficos e incluem: tosse, n√°useas, enjoos, prurido e dor abdominal.",
                    "order": 3,
                    "correct": false,
                    "created_at": "2022-02-10T23:16:10.000Z",
                    "updated_at": "2022-02-11T19:58:52.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 12706,
                "questionary_id": 268235,
                "timer": 0
            }
        },
        {
            "id": 13652,
            "institution_id": 4,
            "description": "Qual das combina√ß√µes farmacol√≥gicas abaixo est√° **CORRETA** perante as terapias antirretrovirais?",
            "difficulty": "hard",
            "year": "2022-01-01T00:00:00.000Z",
            "is_enabled": true,
            "created_at": "2022-04-13T02:19:49.000Z",
            "updated_at": "2022-04-13T02:19:49.000Z",
            "user_id": 5227,
            "is_residency": false,
            "institution": {
                "id": 4,
                "title": "MEDsimple",
                "state": null,
                "is_enabled": true,
                "created_at": "2020-05-16T21:11:41.000Z",
                "updated_at": "2020-05-16T21:11:41.000Z"
            },
            "disciplines": [
                {
                    "id": 124,
                    "title": "HIV/AIDS",
                    "description": null,
                    "parent_id": 21,
                    "is_enabled": true,
                    "created_at": "2020-06-01T00:36:12.000Z",
                    "updated_at": "2020-06-01T00:36:12.000Z",
                    "pivot": {
                        "discipline_id": 124,
                        "question_id": 13652
                    }
                },
                {
                    "id": 21,
                    "title": "Infectologia",
                    "description": null,
                    "parent_id": 3,
                    "is_enabled": true,
                    "created_at": "2020-05-18T23:32:15.000Z",
                    "updated_at": "2020-05-18T23:32:15.000Z",
                    "pivot": {
                        "discipline_id": 21,
                        "question_id": 13652
                    }
                },
                {
                    "id": 172,
                    "title": "Farmacologia",
                    "description": null,
                    "parent_id": 1,
                    "is_enabled": true,
                    "created_at": "2020-06-09T16:52:36.000Z",
                    "updated_at": "2020-06-09T16:52:36.000Z",
                    "pivot": {
                        "discipline_id": 172,
                        "question_id": 13652
                    }
                }
            ],
            "alternatives": [
                {
                    "id": 55937,
                    "question_id": 13652,
                    "description": "Darunavir; Cobicistate; Entricitabina; Tenofovir Alafenamida.",
                    "explanation": "Arrasou, Doc!! üéâ\n\nEssa combina√ß√£o farmacol√≥gica √© **comercialmente conhecida como Symtuza** e deve ser administrada via oral uma vez por dia com alimentos.\n\nVamos relembrar as classes desses f√°rmacos?\n- Darunavir: Inibidor de protease;\n- Cobicistate: Inibidor de enzimas do citocromo P450;\n- Entricitabina: Inibidores nucleos√≠deos da transcriptase reversa;\n- Tenofovir Alafenamida: Inibidores da transcriptase reversa an√°logos de nucleot√≠deo.",
                    "order": 0,
                    "correct": true,
                    "created_at": "2022-04-13T02:19:49.000Z",
                    "updated_at": "2022-04-13T02:19:49.000Z",
                    "files": []
                },
                {
                    "id": 55938,
                    "question_id": 13652,
                    "description": "Doravirina; Lamivudina; Tenofovir Disoproxil Fumarato; Etravirina.",
                    "explanation": "Errado, Doc! üòï\n\nEssa suposta combina√ß√£o cont√©m **dois f√°rmacos** Inibidores n√£o nucleos√≠deos da transcriptase reversa, ou seja, **de clases iguais:** Doravirina e Etravirina.\n\nNesse caso, **a retirada da Etravirina torna o f√°rmaco comercial e seu nome √© Delstrigo**, que deve ser administrado via oral uma vez ao dia e com ou sem alimentos.",
                    "order": 1,
                    "correct": false,
                    "created_at": "2022-04-13T02:19:49.000Z",
                    "updated_at": "2022-04-13T02:19:49.000Z",
                    "files": []
                },
                {
                    "id": 55939,
                    "question_id": 13652,
                    "description": "Entricitabina; Fumarato de Tenofovir Alafenamida; Zidovudina.",
                    "explanation": "Errado, Doc! üòï\n\nEssa suposta combina√ß√£o cont√©m **dois f√°rmacos** inibidores nucleos√≠deos da transcriptase reversa;, ou seja, **de clases iguais:** Entricitabina e Zidovudina.\n\nNesse caso, **a retirada da Zidovudina torna o f√°rmaco comercial e seu nome √© Descovy**, que deve ser administrado via oral uma vez ao dia e com ou sem alimentos.\n\n",
                    "order": 2,
                    "correct": false,
                    "created_at": "2022-04-13T02:19:49.000Z",
                    "updated_at": "2022-04-13T02:19:49.000Z",
                    "files": []
                },
                {
                    "id": 55940,
                    "question_id": 13652,
                    "description": "Rilpivirina; Entricitabina; Tenofovir Disoproxil Fumarato; Fumarato de Tenofovir Alafenamida.",
                    "explanation": "Errado, Doc! üòï\n\nEssa suposta combina√ß√£o cont√©m **dois f√°rmacos** Inibidores da transcriptase reversa an√°logos de nucleot√≠deo, ou seja, **de clases iguais:** Tenofovir Disoproxil Fumarato e Fumarato de Tenofovir Alafenamida.\n\nNesse caso, **a retirada do Fumarato de Tenofovir Alafenamida torna o f√°rmaco comercial e seu nome √© Complera,** que deve ser administrado via oral uma vez ao dia e com alimentos.",
                    "order": 3,
                    "correct": false,
                    "created_at": "2022-04-13T02:19:49.000Z",
                    "updated_at": "2022-04-13T02:19:49.000Z",
                    "files": []
                }
            ],
            "answers": [],
            "files": [],
            "pivot": {
                "question_id": 13652,
                "questionary_id": 268235,
                "timer": 0
            }
        }
    ]
}